Search Grant Opportunities

DoW Traumatic Brain Injury and Psychological Health, Translational Research Award

ID: HT942526TBIPHRPTRA • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Popular Questions:
Generate a draft:
Loading

Description

Posted: May 21, 2026, 12:00 a.m. EDT

Summary: The Translational Research Award (TRA) intends to accelerate the conversion of scientific findings into impactful clinical applications. The TRA prioritizes innovative approaches over purely iterative or incremental research. Submissions focusing on minor modifications to existing standards without the intent or potential to significantly improve clinical care or patient outcomes do not meet the intent of the mechanism.

Distinctive Features: Basic research and clinical trials are prohibited. Preliminary data are required.

For animal research, applications must describe the choice of model and its relevance to the human clinical condition.

For research prospectively enrolling human subjects, the inclusion of community-based participatory research (CBPR) approaches is required.

The Translational Research Award offers funding for two Research Levels. The applicant is responsible for selecting the Research Level based on the scope of the research.

Research Level 1: Supports the refinement of mature ideas and concepts into tangible and knowledge products positioned for further evaluation.

Research Level 2: Supports the rigorous evaluation of tangible and knowledge products in preparation for first-in-human studies or clinical trials.

Early-Career Investigator Partnering Option (available for both Research Levels): This option accommodates two Principal Investigators (PIs), one of which is an Early-Career Investigator. If recommended for funding, each PI will receive a separate award.

Posted: May 6, 2026, 12:00 a.m. EDT
Posted: May 6, 2026, 12:00 a.m. EDT
Posted: May 6, 2026, 12:00 a.m. EDT
Background
The Translational Research Award (TRA) is part of the Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP), managed by the Congressionally Directed Medical Research Programs (CDMRP) under the Defense Health Agency. The TRA aims to accelerate the conversion of scientific findings into impactful clinical applications, prioritizing innovative approaches that significantly improve clinical care and patient outcomes. The TBIPHRP was initiated in response to traumatic brain injuries and psychological health issues experienced by military personnel, with a vision to optimize prevention, assessment, and treatment of these conditions.

Grant Details
The TRA supports research that accelerates the conversion of scientific findings into impactful clinical applications. Basic research and clinical trials are prohibited, and preliminary data are required. Applications must describe animal models relevant to human conditions or include community-based participatory research (CBPR) approaches for human subject research. The award offers two Research Levels: Level 1 supports refinement of mature ideas into tangible products, while Level 2 supports rigorous evaluation in preparation for first-in-human studies. An Early-Career Investigator Partnering Option allows for two Principal Investigators (PIs), one being an Early-Career Investigator. The maximum funding is $1.0M for Research Level 1 and $2.0M for Research Level 2, with a total budget of approximately $9.0M allocated for this program.

Eligibility Requirements
Eligible applicants include U.S. Department of War organizations, both extramural and intramural, as well as foreign and domestic organizations, for-profit and nonprofit entities. Principal Investigators must be independent investigators affiliated with eligible organizations; individuals in mentored positions are not eligible. For the Early-Career Investigator Partnering Option, at least one PI must be within 10 years post-terminal degree completion.

Period of Performance
The maximum period of performance is 4 years from the award date.

Grant Value
The total value of the grant is approximately $9.0 million, with individual awards capped at $1.0 million for Research Level 1 and $2.0 million for Research Level 2.

Overview

Category of Funding
Science and Technology and other Research and Development
Funding Instruments
Grant
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 5/21/26 U.S. Army Medical Research Acquisition Activity posted grant opportunity HT942526TBIPHRPTRA for DoW Traumatic Brain Injury and Psychological Health, Translational Research Award with funding of $9.0 million. The grant will be issued under grant program 12.420 Military Medical Research and Development. It is expected that 6 total grants will be made.

Timing

Posted Date
May 21, 2026, 12:00 a.m. EDT
Closing Date
Oct. 15, 2026, 12:00 a.m. EDT Due in 137 Days
Last Updated
May 21, 2026, 1:47 p.m. EDT
Version
1
Archive Date
Nov. 14, 2026

Eligibility

Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Award Sizing

Ceiling
Not Listed
Floor
Not Listed
Estimated Program Funding
$9,000,000
Estimated Number of Grants
6

Contacts

Contact
Teresa M Parker-Reeser Grants Officer
Contact Email
Email Description
eBRAP Help Desk
Contact Phone
(301) 619-2171

Documents

Posted documents for HT942526TBIPHRPTRA

Opportunity Assistant


AI Analysis

AI Generate

Potential Applicants and Partners

Awardees that have recently won grants similar to HT942526TBIPHRPTRA

Incumbent or Similar Grants

Grants similar to HT942526TBIPHRPTRA

Similar Active Opportunities

Open grant opportunities similar to HT942526TBIPHRPTRA

Experts for DoW Traumatic Brain Injury and Psychological Health, Translational Research Award

Recommended subject matter experts available for hire